Jazz Pharma Opts In, Advances Zanidatamab Partnership With Zymeworks
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) exercised its option to continue with its exclusive development and commercialization rights to Zymeworks Inc’s (NASDAQ:ZYME) zanidatamab in key…